Carboxymethylcellulose based self-healing hydrogel with coupled DOX as Camptothecin loading carrier for synergetic colon cancer treatment

Int J Biol Macromol. 2023 Sep 30:249:126012. doi: 10.1016/j.ijbiomac.2023.126012. Epub 2023 Jul 29.

Abstract

The self-healing hydrogels have important applications in biomedication as drug release carrier. In this research, the Doxorubicin (DOX) was coupled onto oxidized carboxymethylcellulose (CMC) (CMC-Ald) to fabricate self-healing hydrogel with intrinsic antitumor property and loaded with Camptothecin (CPT) for synergetic antitumor treatment. The DOX coupled CMC-Ald (CMC-AD) was reacted with poly(aspartic hydrazide) (PAH) to fabricate injectable self-healing hydrogel. The coupled DOX avoided the burst release of the drug and the 100 % CPT loaded hydrogel could take the advantages of both drugs to enhance the synergetic antitumor therapeutic effect. The in vitro and in vivo results revealed the CPT loaded CMC-AD/PAH hydrogel showed enhanced antitumor property and reduced biotoxicity of the drugs. These properties demonstrate that the CMC-AD/PAH hydrogel has great application prospects in biomedication.

Keywords: Antitumor therapy; Carboxymethyl cellulose; Controlled drug release; Hydrogels; Self-healable.

MeSH terms

  • Camptothecin / pharmacology
  • Carboxymethylcellulose Sodium
  • Colonic Neoplasms* / drug therapy
  • Doxorubicin / pharmacology
  • Drug Carriers
  • Drug Liberation
  • Humans
  • Hydrogels*

Substances

  • Hydrogels
  • Carboxymethylcellulose Sodium
  • Doxorubicin
  • Drug Carriers
  • Camptothecin